In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was presented at the 2014 San Antonio Breast Cancer Symposium. Listen to the podcast to hear Dr. Wojciechowski explain:

results of a study that found that Aromasin plus ovarian suppression reduced recurrence risk better than tamoxifen plus ovarian suppression in some women diagnosed with early-stage, hormone-receptor-positive disease

research that underscored the long-term benefits of tamoxifen for reducing risk in women with a higher-than-average risk of breast cancer who’ve never been diagnosed

a study showing that Faslodex worked better than Arimidex as a first treatment for women newly diagnosed with advanced-stage breast cancer

research conducted in part by Breastcancer.org that shows that breastfeeding, even for a short time, reduces breast cancer risk more than previously thought

why a low-fat diet improved survival in women diagnosed with hormone-receptor-negative breast cancer

Running time: 16:01

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was published in November 2014. Listen to the podcast to hear Dr. Wojciechowski explain:

results of a study that found calcium channel blockers, a common type of high blood pressure medicine, don’t increase breast cancer risk

new guidelines from the Society for Integrative Oncology on complementary therapies for breast cancer

why more U.S. women are choosing mastectomy over lumpectomy to remove early-stage breast cancer

how the experimental targeted therapy olaparib works and why it may work against advanced-stage cancers in people with an abnormal BRCA1 or BRCA2 gene

Running time: 17:13

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was published in October 2014. Listen to the podcast to hear Dr. Wojciechowski explain:

results of a study that found the targeted therapy Herceptin offers long-lasting benefits for women diagnosed with early-stage HER2-positive disease

a study that found occult cancers in more than 2% of women who were having their ovaries removed preventively because of genetics or family history

why Hispanic women still need to take steps to reduce their risk of breast cancer, even if they have a genetic variant that may lower their risk

why more research is needed before a new genomic test can be used to make treatment decisions

Running time: 13:40

In this Breastcancer.org podcast, Marisa Weiss, M.D., Breastcancer.org’s chief medical officer, discusses a study examining survival rates after lumpectomy plus radiation or mastectomy for early-stage breast cancer. The study was presented at the 2015 San Antonio Breast Cancer Symposium Dec. 8-12. Listen to the podcast to hear Dr. Weiss explain:

why lumpectomy plus radiation and mastectomy are both good choices for early-stage breast cancer surgery

why one type of surgery might be recommended over the other

why the researchers think there might have been a difference in survival rates

Running time: 11:27

In this podcast, Marisa Weiss, M.D., Breastcancer.org’s chief medical officer, explains a study that looked at the effectiveness of Arimidex and tamoxifen for reducing risk after DCIS surgery and radiation, as well as the side effects of each medicine. The study was presented at the 2015 San Antonio Breast Cancer Symposium, December 8-12. Listen to the podcast to hear Dr. Weiss explain:

what DCIS is

why postmenopausal women should be reassured no matter which of these medicines they’re taking

the side effects of each medicine

Running time: 11:26

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was published in September and October 2014. Listen to the podcast to hear Dr. Wojciechowski explain:

results of a study that found the targeted therapy Perjeta increased overall survival by about 1.5 years in women diagnosed with HER2-positive metastatic breast cancer

why wearing a bra IS NOT linked to breast cancer risk

why breastfeeding decreases breast cancer risk

how Trelstar might increase the chances that some premenopausal women get pregnant after going through breast cancer treatment

Running time: 18:03

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was published in August and September 2014. Listen to the podcast to hear Dr. Wojciechowski explain:

results of a study that found an abnormal PALB2 gene increases breast cancer risk more than previously thought

why bisphosphonates don’t reduce risk in women who’ve never been diagnosed with breast cancer

the risk-reducing benefits of exercise for postmenopausal women

the risks and benefits of double mastectomy versus lumpectomy plus radiation for women at average risk diagnosed with breast cancer in just one breast

Running time: 19:34

In this podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was published in July 2014. Listen to the podcast to hear Dr. Wojciechowski talk about:

why treating inflammatory breast cancer with three treatments -- chemotherapy, surgery, and radiation -- improves survival compared to using only one or two of these treatments

the reasons why having more moles is linked to a higher risk of breast cancer, though moles themselves DO NOT cause breast cancer

research showing that women with an abnormal BRCA1 gene -- but not an abnormal BRCA2 gene -- diagnosed with breast cancer are more likely to survive if they have their ovaries and fallopian tubes removed

a study that found combining 3-D mammograms (digital tomosynthesis) and digital mammograms find more breast cancers with fewer false positives

Running time: 20:50

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was published in May 2014 or presented at the American Society of Clinical Oncology Annual Meeting in June 2014. Listen to the podcast to hear Dr. Wojciechowski explain:

why using Aromasin on top of ovarian suppression medicine is better at reducing risk in premenopausal women than tamoxifen on top of ovarian suppression medicine

why some research studies on any links between vitamin D and breast cancer outcomes seem to have mixed results

the American Society of Clinical Oncology special series of articles on pain in people diagnosed with cancer

why childhood cancer survivors have a higher risk of breast cancer, even if they didn’t have radiation to the chest area

Running time: 21:44

In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, discusses some of the most talked-about studies that came out in April 2014. Listen to the podcast to hear Dr. Wojciechowski explain:

the new American Association of Clinical Oncology (ASCO) guidelines on sentinel lymph node biopsy for people diagnosed with early-stage disease

more guidelines from ASCO on issues faced by survivors, including chemotherapy-induced neuropathy, fatigue, and depression

how healthy eating improves survival

why an individualized approach to mammography screening is needed

Running time: 27:02